SoftOx Solutions AS — Regulatory Filings 2021

Aug 31, 2021

SOFTOX SOLUTIONS AS WINS NATIONAL HOSPITAL TENDER FOR HAND DISINFECTANTS

SOFTOX SOLUTIONS AS WINS NATIONAL HOSPITAL TENDER FOR HAND DISINFECTANTS

Sykehusinnkjøp HF’s national tender – hygiene products, disinfectants and dispensing solutions for hand disinfectants, soap and cream (HINAS).

SoftOx Solutions AS (SoftOx) has participated in the HINAS tender mentioned here and reports that the company’s hand disinfectant product SafeDes® has been selected and will be listed in Norwegian hospitals as the only alternative to alcohol-based products following the decision in the national tender.

From the evaluation for subcontract 16, hand disinfectants without alcohol (bottles), SoftOx received a top score on the evaluation criteria “properties on skin” and quality. The product is an alternative for those who have skin problems related to the use of alcohol. The skin does not feel sticky or dry after use.

This, in combination with a competitive price, is the overall evaluation that SoftOx comes out best in the assessment.

The product has been assessed by the country's foremost professional expertise on efficacy and safety in disinfection. This is a confirmation of our base technology, and the decision clearly shows that the product has a place in the health care system. "Winning a national hospital tender is also a very important reference for the company in other markets, in addition to being a confirmation of our research and our work so far. This award shows that our commitment to health has been right and provides a good basis for further investment," says CEO Geir Almås.

The company announces increased investment in its disinfection products. Based on the clear advantages of the products: skin friendliness, effect and security, we will continue to invest in the categories defense, health, B2B and the transportation industry. We now see that the market responds within these categories and are experiencing increased demand and sales. However, the Norwegian hospital market is the company’s pilot customer and is not expected to provide profitability during the first years.

With reference to the stock exchange announcement on 2 July 2021, the company is still working on the basis that company will enter a transitional arrangement in the connection with the new biocidal regulations.

Further information, please contact:

Geir Almås, CEO of SoftOx Solutions AS, or

Mail: ir@soft-ox.com

Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS

SoftOx Solutions AS is a Norwegian BioTech company listed on Euronext Growth

Oslo. Our vision is “Helping the world fighting infections - developing new ways

of eradicating infections and fighting antimicrobial resistance”. We are working

to combat major threats to human health, namely the emergence of antimicrobial

resistance (AMR), biofilm infections in chronic wounds and the spread of

viruses. For more information on SoftOx, visit www.soft-ox.com.